Sangiovanni Timothy J. 4
4 · KEMPHARM, INC · Filed Mar 10, 2020
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Sangiovanni Timothy J.
SVP, Finance & Corp Controller
Transactions
- Purchase
Common Stock
2020-03-10$0.25/sh+10$3→ 6,343 total - Purchase
Common Stock
2020-03-09$0.25/sh+333$83→ 6,333 total - Purchase
Common Stock
2020-03-10$0.26/sh+7,657$1,953→ 14,000 total